These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31259314)

  • 21. Adding experimental arms to platform clinical trials: randomization procedures and interim analyses.
    Ventz S; Cellamare M; Parmigiani G; Trippa L
    Biostatistics; 2018 Apr; 19(2):199-215. PubMed ID: 29036330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MONALISA for stochastic simulations of Petri net models of biochemical systems.
    Balazki P; Lindauer K; Einloft J; Ackermann J; Koch I
    BMC Bioinformatics; 2015 Jul; 16():215. PubMed ID: 26156221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Building a virtual simulation platform for quasistatic breast ultrasound elastography using open source software: A preliminary investigation.
    Wang Y; Helminen E; Jiang J
    Med Phys; 2015 Sep; 42(9):5453-66. PubMed ID: 26328994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTS: a clinical trials simulator.
    Taylor DW; Bosch EG
    Stat Med; 1990 Jul; 9(7):787-801. PubMed ID: 2218181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of methodological considerations regarding adaptive stopping, arm dropping, and randomization in clinical trials.
    Granholm A; Kaas-Hansen BS; Lange T; Schjørring OL; Andersen LW; Perner A; Jensen AKG; Møller MH
    J Clin Epidemiol; 2023 Jan; 153():45-54. PubMed ID: 36400262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized adaptive enrichment designs for three-arm trials: learning which subpopulations benefit from different treatments.
    Steingrimsson JA; Betz J; Qian T; Rosenblum M
    Biostatistics; 2021 Apr; 22(2):283-297. PubMed ID: 31420983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simulation study of outcome adaptive randomization in multi-arm clinical trials.
    Wathen JK; Thall PF
    Clin Trials; 2017 Oct; 14(5):432-440. PubMed ID: 28982263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and monitoring of multi-arm multi-stage clinical trials.
    Ghosh P; Liu L; Senchaudhuri P; Gao P; Mehta C
    Biometrics; 2017 Dec; 73(4):1289-1299. PubMed ID: 28346823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decision rules for identifying combination therapies in open-entry, randomized controlled platform trials.
    Meyer EL; Mesenbrink P; Dunger-Baldauf C; Glimm E; Li Y; König F;
    Pharm Stat; 2022 May; 21(3):671-690. PubMed ID: 35102685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian adaptive trials for rare cardiovascular conditions.
    Shohoudi A; Stephens DA; Khairy P
    Future Cardiol; 2018 Mar; 14(2):143-150. PubMed ID: 29405070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
    Wang H; Rosner GL; Goodman SN
    Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of In-Browser Simulators for Medical Education: Introduction of a Novel Software Toolchain.
    Šilar J; Polák D; Mládek A; Ježek F; Kurtz TW; DiCarlo SE; Živný J; Kofranek J
    J Med Internet Res; 2019 Jul; 21(7):e14160. PubMed ID: 31271154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Information time scales for interim analyses of randomized clinical trials.
    Freidlin B; Othus M; Korn EL
    Clin Trials; 2016 Aug; 13(4):391-9. PubMed ID: 27136947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of biomarker diagnostic accuracy on biomarker-guided phase 2 trials.
    Park JJ; Harari O; Dron L; Mills EJ; Thorlund K
    Contemp Clin Trials Commun; 2019 Sep; 15():100396. PubMed ID: 31294127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical concepts in adaptive clinical trials.
    Park JJ; Thorlund K; Mills EJ
    Clin Epidemiol; 2018; 10():343-351. PubMed ID: 29606891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian Adaptive Randomization and Trial Monitoring with Predictive Probability for Time-to-event Endpoint.
    Yin G; Chen N; Lee JJ
    Stat Biosci; 2018 Aug; 10(2):420-438. PubMed ID: 30559900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS.
    van Unnik JWJ; Nikolakopoulos S; Eijkemans MJC; Gonzalez-Bermejo J; Bruneteau G; Morelot-Panzini C; van den Berg LH; Cudkowicz ME; McDermott CJ; Similowski T; van Eijk RPA;
    Neurology; 2023 Jun; 100(23):e2398-e2408. PubMed ID: 37085329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ComPAS: A Bayesian drug combination platform trial design with adaptive shrinkage.
    Tang R; Shen J; Yuan Y
    Stat Med; 2019 Mar; 38(7):1120-1134. PubMed ID: 30419609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unified exact design with early stopping rules for single arm clinical trials with multiple endpoints.
    Wei W; Esserman D; Kane M; Zelterman D
    Stat Methods Med Res; 2021 Jul; 30(7):1575-1588. PubMed ID: 34159859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The life cycles of six multi-center adaptive clinical trials focused on neurological emergencies developed for the Advancing Regulatory Science initiative of the National Institutes of Health and US Food and Drug Administration: Case studies from the Adaptive Designs Accelerating Promising Treatments Into Trials Project.
    Guetterman TC; Fetters MD; Mawocha S; Legocki LJ; Barsan WG; Lewis RJ; Berry DA; Meurer WJ
    SAGE Open Med; 2017; 5():2050312117736228. PubMed ID: 29085638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.